Nikola Hagedorn

Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group

Cornelia Eckert, Günter Henze, K. Seeger et al. · Journal of Clinical Oncology · 2013 · 164 citations

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Nikola Hagedorn, Cécile Acquaviva, Eva Froňková et al. · Blood · 2007 · 99 citations · Full text

Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment

Cornelia Eckert, Nikola Hagedorn, Lucie Šrámková et al. · Leukemia · 2015 · 67 citations

Hematological Malignancy, Prognostic Evaluation, Pediatric Epidemiology +10

Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment

Cornelia Eckert, T Flohr, Rolf Koehler et al. · Leukemia · 2011 · 30 citations

Hematological Malignancy, Lymphoid Neoplasia, Relapse Treatment +10

Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics

Cornelia Eckert, Stefanie Groeneveld‐Krentz, Renate Kirschner‐Schwabe et al. · Journal of Clinical Oncology · 2019 · 30 citations · Full text